Monday, May 29, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - Shareholders say Micromet is selling itself too cheaply to Amgen, for $11 a share or $1.16 billion, in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...